These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37988189)

  • 61. Identification of a Transcription Factor Signature That Can Predict Breast Cancer Survival.
    Fan C; Du J; Liu N
    Comput Math Methods Med; 2021; 2021():2649123. PubMed ID: 33688372
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
    Sun M; Tang C; Liu J; Jiang W; Yu H; Dong F; Huang C; Rixiati Y
    BMC Cancer; 2021 Jun; 21(1):696. PubMed ID: 34120621
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Integrative analysis based on the cell cycle-related genes identifies TPX2 as a novel prognostic biomarker associated with tumor immunity in breast cancer.
    Liu X; Wang W; Chen B; Wang S
    Aging (Albany NY); 2024 Apr; 16(8):7188-7216. PubMed ID: 38643462
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Heparanase is a novel biomarker for immune infiltration and prognosis in breast cancer.
    Yang WJ; Shi L; Wang XM; Yang GW
    Aging (Albany NY); 2021 Aug; 13(16):20836-20852. PubMed ID: 34461608
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
    Xu H; Xiong C; Chen Y; Zhang C; Bai D
    Bioengineered; 2021 Dec; 12(1):2664-2675. PubMed ID: 34115569
    [TBL] [Abstract][Full Text] [Related]  

  • 66. HJURP is a prognostic biomarker for clear cell renal cell carcinoma and is linked to immune infiltration.
    Zhang F; Yuan D; Song J; Chen W; Wang W; Zhu G; Hu B; Chen X; Zhu J
    Int Immunopharmacol; 2021 Oct; 99():107899. PubMed ID: 34217993
    [TBL] [Abstract][Full Text] [Related]  

  • 67. PTP4A3 Is a Prognostic Biomarker Correlated With Immune Infiltrates in Papillary Renal Cell Carcinoma.
    Song Q; Zheng Y; Wu J; Wang S; Meng L; Yao Q; Li Z; Lian S
    Front Immunol; 2021; 12():717688. PubMed ID: 34630392
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer.
    Qiu P; Guo Q; Yao Q; Chen J; Lin J
    Front Immunol; 2021; 12():736030. PubMed ID: 34659224
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma.
    Peng Y; Yu H; Zhang Y; Qu F; Tang Z; Qu C; Tian J; Zong B; Wang Y; Ren H; Liu S
    Sci Rep; 2021 Sep; 11(1):17610. PubMed ID: 34475496
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma.
    Pan L; Fang J; Chen MY; Zhai ST; Zhang B; Jiang ZY; Juengpanich S; Wang YF; Cai XJ
    World J Gastroenterol; 2020 Feb; 26(8):789-803. PubMed ID: 32148377
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comprehensive Analysis of the Associations of LOXL1-4 with Prognosis and Immune Infiltration in Breast Cancer.
    He L; Lin Y; Huang P; Pan H
    Altern Ther Health Med; 2024 Mar; ():. PubMed ID: 38518152
    [TBL] [Abstract][Full Text] [Related]  

  • 72. BUBs Are New Biomarkers of Promoting Tumorigenesis and Affecting Prognosis in Breast Cancer.
    Wang S; Liu X; Yang M; Yuan D; Ye K; Qu X; Wang X
    Dis Markers; 2022; 2022():2760432. PubMed ID: 35493295
    [TBL] [Abstract][Full Text] [Related]  

  • 73. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The prognostic implications and tumor-suppressive functions of CYR61 in estrogen receptor-positive breast cancer.
    Zhang C; Li Z; Hu K; Ren Y; Zhang H; Zhao Y; Wei W; Tu S; Yan X
    Front Immunol; 2023; 14():1308807. PubMed ID: 38259466
    [TBL] [Abstract][Full Text] [Related]  

  • 75. FN1 overexpression is correlated with unfavorable prognosis and immune infiltrates in breast cancer.
    Zhang XX; Luo JH; Wu LQ
    Front Genet; 2022; 13():913659. PubMed ID: 36035176
    [No Abstract]   [Full Text] [Related]  

  • 76. BTN3A2 serves as a prognostic marker and favors immune infiltration in triple-negative breast cancer.
    Cai P; Lu Z; Wu J; Qin X; Wang Z; Zhang Z; Zheng L; Zhao J
    J Cell Biochem; 2020 Mar; 121(3):2643-2654. PubMed ID: 31692043
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Low KRT15 expression is associated with poor prognosis in patients with breast invasive carcinoma.
    Zhong P; Shu R; Wu H; Liu Z; Shen X; Hu Y
    Exp Ther Med; 2021 Apr; 21(4):305. PubMed ID: 33717248
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer.
    Wu Q; Zheng S; Lin N; Xie X
    BMC Med Genomics; 2023 Apr; 16(1):87. PubMed ID: 37098532
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The Expression of RTN1 in Lung Adenocarcinoma and 
Its Effect on Immune Microenvironment].
    Zhu S; Zu L; Xu S
    Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.